not tagged
not tagged
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
l bbert et al. phase 3 trial. - 3+7 vs. decitabine in over 60-year-old aml patients eligible for first-line intensive therapy. - similar os
- dec has a better safety and health economics profile than 3+7
- &gt;50% overall transplant rate in both arms #amlsm #leusm #eha2022 #eha22 
Senior researcher (@IKNL, @ErasmusMC, @AmsterdamUMC) leading population-based cancer research in the Netherlands. Tweets are my own. #leusm #lymsm #crypto #xrp